Past, Present, and Future Perspectives on Computer-Aided Drug Design Methodologies

Abstract

The application of computational approaches in drug discovery has been consolidated in the last decades. These families of techniques are usually grouped under the common name of “computer-aided drug design” (CADD), and they now constitute one of the pillars in the pharmaceutical discovery pipelines in many academic and industrial environments. Their implementation has been demonstrated to tremendously improve the speed of the early discovery steps, allowing for the proficient and rational choice of proper compounds for a desired therapeutic need among the extreme vastness of the drug-like chemical space. Moreover, the application of CADD approaches allows the rationalization of biochemical and interactive processes of pharmaceutical interest at the molecular level. Because of this, computational tools are now extensively used also in the field of rational 3D design and optimization of chemical entities starting from the structural information of the targets, which can be experimentally resolved or can also be obtained with other computer-based techniques. In this work, we revised the state-of-the-art computer-aided drug design methods, focusing on their application in different scenarios of pharmaceutical and biological interest, not only highlighting their great potential and their benefits, but also discussing their actual limitations and eventual weaknesses. This work can be considered a brief overview of computational methods for drug discovery.

Exploring Citrus sinensis Phytochemicals as Potential Inhibitors for Breast Cancer Genes BRCA1 and BRCA2 Using Pharmacophore Modeling, Molecular Docking, MD Simulations, and DFT Analysis

“…Computer-aided drug design has become the latest process in drug development against multiple diseases and has become popular in the pharmaceutical industry in no time. Due to the presence of modern computational tools, the technique helps in the analysis, management as well as modeling of compounds or ligands while traditional methods are risky, expensive, laborious, and time-consuming. , Different stages of CADD (Figure ) include the identification of targeted protein, lead discovery, protein validation, and lead optimization . This technique explains the binding affinities and the interaction of the protein and ligand.…”

Site Identification and Next Choice Protocol for Hit-to-Lead Optimization

“…In the third stage, the lead compound is optimized to maintain a favorable affinity and improve pharmacokinetics . Recently, target-to-hit and lead optimization stages have become more efficient owing to computational tools such as docking simulation, molecular dynamics (MD) simulation, and artificial intelligence. − …”

Enhancing Opioid Bioactivity Predictions through Integration of Ligand-Based and Structure-Based Drug Discovery Strategies with Transfer and Deep Learning Techniques

“…1,2 To expedite and improve the drug discovery process, computer-aided drug discovery techniques can be invaluable. 3 There are two main approaches in computer-aided drug discovery: ligand-based (LB) and structure-based (SB) methods. LB methods can help in the design of novel opioid ligands by predicting their biological activity based on shared molecular descriptors with known opioids.…”

“…To expedite and improve the drug discovery process, computer-aided drug discovery techniques can be invaluable . There are two main approaches in computer-aided drug discovery: ligand-based (LB) and structure-based (SB) methods.…”